Carbon dioxide laser treatment for vulval papillomatosis (vulvodynia)
Article first published online: 19 AUG 2005
DOI: 10.1111/j.1471-0528.1990.tb02505.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b)
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 97, Issue 12, pages 1148–1150, December 1990
Additional Information
How to Cite
SHAFT, M. T., FINN, C., LUESLEY, D. M., JORDAN, J. A. and ROLLASON, T. P. (1990), Carbon dioxide laser treatment for vulval papillomatosis (vulvodynia). BJOG: An International Journal of Obstetrics & Gynaecology, 97: 1148–1150. doi: 10.1111/j.1471-0528.1990.tb02505.x
Publication History
- Issue published online: 19 AUG 2005
- Article first published online: 19 AUG 2005
- Received 9 March 1990 Accepted 6 June 1990
- Abstract
- References
- Cited By
Summary. Genital papillomatosis accompanied by distressing vulval symptoms is often termed vulvodynia. Common presenting symptoms are vulvar burning, pruritus and dyspareunia. Sixteen patients with vulval papillomatosis (vulvodynia) have been treated by carbon dioxide laser therapy over a 4-year period. Initial responses at 6 weeks appeared encouraging but with follow-up it became apparent that the relapse rate was high, with a mean symptom-free interval of 4–6 months. Of the 16 patients treated, only three remain symptom free. In view of our findings, we recommend that laser therapy should not be offered as a primary procedure, if at all, for patients with vulval papillomatosis.

1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)